The long-term impact of obesity in pregnancy on offspring hypothalamic feeding pathways

Pit Shan Chong1, Laura Dearden1

  • 1Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Royal Society Open Science
|November 17, 2025
PubMed

Insights

Maternal obesity during pregnancy increases offspring obesity risk by altering fetal hypothalamic development. Key mechanisms include epigenetic changes and gut-brain axis disruptions, impacting lifelong feeding behaviors and metabolic health.

Area of Science:

  • Reproductive Biology
  • Neuroscience
  • Metabolic Health

Background:

  • Maternal obesity is a growing concern linked to increased offspring obesity risk.
  • Offspring obesity is associated with altered feeding behaviors and hypothalamic dysfunction.
  • The prenatal environment significantly influences long-term metabolic programming.

Purpose of the Study:

  • To review how maternal obesity affects fetal hypothalamic development.
  • To elucidate molecular mechanisms mediating offspring metabolic dysfunction.
  • To highlight knowledge gaps and emerging research in intergenerational obesity transmission.

Main Methods:

  • Review of human and animal studies on maternal obesity and offspring development.
  • Analysis of molecular pathways involved in hypothalamic programming.
  • Examination of epigenetic modifications, hormonal disruption, neuroinflammation, and gut-brain axis interactions.

Main Results:

  • Maternal obesity alters fetal hypothalamic development, predisposing offspring to obesity.
  • Epigenetic changes, hormonal disruption, neuroinflammation, and gut-brain axis alterations are key mediators.
  • Specific molecular pathways driving neurodevelopmental changes require further investigation.

Conclusions:

  • Understanding maternal obesity's impact on fetal hypothalamic development is crucial for preventing intergenerational obesity.
  • Interventions targeting molecular mechanisms can mitigate long-term metabolic dysfunction in offspring.
  • Further research into maternal-fetal communication, including extracellular vesicles, is warranted.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K